HOME >> MEDICINE >> NEWS
Interferon with ribavirin is safe and effective for children with chronic Hepatitis C

Nearly half of 118 children with chronic Hepatitis C virus (HCV) treated with a combination of interferon-alpha-2b and an optimized dose of ribavirin achieved sustained viral response, and side effects were generally mild. These results are reported in the November 2005 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD).

Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.

HCV is usually asymptomatic in children though it can lead to serious liver damage. Treatment with interferon is standard and induces lasting remission in more than a third of infected children. The addition of ribavirin to treatment with interferon has been shown to markedly improve outcomes for adults with HCV, but the combination has not been extensively studied in children. Led by Regino Gonzlez-Peralta, M.D. of the Division of Pediatric Gastroenterology, Hepatology, and Nutrition at the University of Florida, researchers addressed combination therapy for children with a twofold program.

The first part searched for the optimal dose of ribavirin for children with HCV while testing the drug's safety and efficacy. Fifty-six children, ages five to 16, were randomly assigned to take interferon along with ribavirin in varying doses for 48 weeks. They were evaluated for efficacy and side effects at regular intervals, and followed-up for an additional 24 weeks. By the end of the follow-up period, 35 percent of children taking 8 mg/kg/day of ribavirin, 37 percent taking 12 mg/kg/day, and 47 percent of 15/mg/kg/day had undetectable levels of HCV in their blood. Side effects were similar among all doses. Based on this data, the researchers selected the dosage 15 mg/kg/day for further study.

In all, 118 children with HCV received the optimized treatment
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
1-Nov-2005


Page: 1 2

Related medicine news :

1. Interferon-treated hepatitis C patients likely to experience retinopathy
2. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
3. New treatment effective in counteracting cocaine-induced symptoms
4. Osteoporosis screening and treatment may be cost-effective for selected older men
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. New study examines effectiveness of tailored health messages
7. Scaling up HIV prevention programs is cost effective
8. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
9. U of M researchers assess effectiveness of computerized physician order entry system
10. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
11. Meningitis: effectiveness of preventive vaccination demonstrated

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... 24, 2017 , ... Inspiration, Community & Mentorship – Top ... the Fordham Institute’s High Stakes for High Achievers offer recommendations for ... or high-achieving students as a subgroup and reporting their results separately. Top students ...
(Date:1/24/2017)... Pass, OR (PRWEB) , ... January 24, 2017 ... ... Gerald H. Pollack, Ph.D., http://www.faculty.washington.edu/ghp , Sharon Kleyne, the nation’s foremost ... of Water, Global Climate Change and Your Health on Voice America, once again ...
(Date:1/24/2017)... ... 24, 2017 , ... A yellow fever outbreak in Brazil has infected over ... is primarily spread through contact with infected mosquitos. The outbreak has sparked increased concern ... spread. , According to multiple health organizations, the best way to prevent yellow fever ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... topics like finances, friendship, marriage, leadership, gossip, prostitution, adultery, anger, and common sense. ... authors, Dr. Judith Coats and Dr. David Coats. In September of 1983, they ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... “Mysteries Revealed ... to be a mysterious phenomenon is available to all Christians. “Mysteries Revealed On Speaking ... host of “U Beautiful Creation,” a Christian-based talk show located in Michigan. , ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017 Mezzion has filed ... Jersey State court alleging that Dr. Reddy,s committed fraud ... Food and Drug Administration (FDA) cGMP practices, and misrepresenting ... Reddy,s repeatedly represented to Mezzion that it was compliant ... from Mezzion.  The suit also states that Dr. Reddy,s ...
(Date:1/24/2017)... , January 24, 2017 The global  active pharmaceutical ... billion by 2025, based on a new report by Grand View Research, ... projected to drive the market over the forecast period. Advancements in recombinant ... estimated to boost growth.  Continue Reading ... ...
(Date:1/24/2017)... , January 24, 2017 Aptuit, ... Molecular Surgical Laboratory des Massachusetts General Hospital (MGH) unter ... geht es um die Identifizierung und Validierung neuartiger Targets ... dass sie der Resistenz von Antibiotika bei der Behandlung ... ...
Breaking Medicine Technology:
Cached News: